Review of genetic and epigenetic alterations in hepatocarcinogenesis
- PMID: 16706806
- DOI: 10.1111/j.1440-1746.2005.04043.x
Review of genetic and epigenetic alterations in hepatocarcinogenesis
Abstract
Hepatocellular carcinoma (HCC) is associated with multiple risk factors and is believed to arise from pre-neoplastic lesions, usually in the background of cirrhosis. However, the genetic and epigenetic events of hepatocarcinogenesis are relatively poorly understood. HCC display gross genomic alterations, including chromosomal instability (CIN), CpG island methylation, DNA rearrangements associated with hepatitis B virus (HBV) DNA integration, DNA hypomethylation and, to a lesser degree, microsatellite instability. Various studies have reported CIN at chromosomal regions, 1p, 4q, 5q, 6q, 8p, 10q, 11p, 16p, 16q, 17p and 22q. Frequent promoter hypermethylation and subsequent loss of protein expression has also been demonstrated in HCC at tumor suppressor gene (TSG), p16, p14, p15, SOCS1, RIZ1, E-cadherin and 14-3-3 sigma. An interesting observation emerging from these studies is the presence of a methylator phenotype in hepatocarcinogenesis, although it does not seem advantageous to have high levels of microsatellite instability. Methylation also appears to be an early event, suggesting that this may precede cirrhosis. However, these genes have been studied in isolation and global studies of methylator phenotype are required to assess the significance of epigenetic silencing in hepatocarcinogenesis. Based on previous data there are obvious fundamental differences in the mechanisms of hepatic carcinogenesis, with at least two distinct mechanisms of malignant transformation in the liver, related to CIN and CpG island methylation. The reason for these differences and the relative importance of these mechanisms are not clear but likely relate to the etiopathogenesis of HCC. Defining these broad mechanisms is a necessary prelude to determine the timing of events in malignant transformation of the liver and to investigate the role of known risk factors for HCC.
Similar articles
-
Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.J Pathol. 2000 Oct;192(2):207-15. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH690>3.0.CO;2-#. J Pathol. 2000. PMID: 11004697
-
Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.Hepatology. 2000 Nov;32(5):970-9. doi: 10.1053/jhep.2000.19797. Hepatology. 2000. PMID: 11050047
-
Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis.Cancer Res. 2007 May 15;67(10):4586-94. doi: 10.1158/0008-5472.CAN-06-3464. Cancer Res. 2007. PMID: 17510384
-
[Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].Ai Zheng. 2005 Jun;24(6):757-68. Ai Zheng. 2005. PMID: 15946497 Review. Chinese.
-
An update on the molecular genetics of hepatocellular carcinoma.Semin Liver Dis. 2004 Feb;24(1):77-88. doi: 10.1055/s-2004-823102. Semin Liver Dis. 2004. PMID: 15085488 Review.
Cited by
-
Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study.Carcinogenesis. 2012 Jul;33(7):1340-5. doi: 10.1093/carcin/bgs160. Epub 2012 May 12. Carcinogenesis. 2012. PMID: 22581841 Free PMC article.
-
Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma.Onco Targets Ther. 2016 Aug 1;9:4773-83. doi: 10.2147/OTT.S103940. eCollection 2016. Onco Targets Ther. 2016. PMID: 27536140 Free PMC article.
-
Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma.Oncotarget. 2016 Aug 30;7(35):56798-56810. doi: 10.18632/oncotarget.10792. Oncotarget. 2016. PMID: 27462864 Free PMC article.
-
Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs.Sci Rep. 2018 Mar 19;8(1):4842. doi: 10.1038/s41598-018-23318-1. Sci Rep. 2018. PMID: 29555949 Free PMC article.
-
Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan.World J Hepatol. 2016 Feb 18;8(5):301-6. doi: 10.4254/wjh.v8.i5.301. World J Hepatol. 2016. PMID: 26925204 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous